Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Detroit MI, Toronto, Buffalo NY, Bethesda MD,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
for
Cancer
Location: Detroit MI, Chicago IL, Fairfax VA, Philadelphia PA,
Location: Detroit MI, Grand Rapids MI, Columbus OH, Pittsburgh PA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase1, Phase2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Detroit MI, Columbus OH, Chicago IL, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase1, Phase2, Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Location: Detroit MI, Silver Spring MD, Dallas TX, Houston TX
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase1, Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Detroit MI, Fairfax VA, Nashville TN, Manhattan NY,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase1, Phase2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Detroit MI, Columbus OH, Toronto, Pittsburgh PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)